Sarah Lindsey, PhD

Sex differences and estrogen receptor signaling in cardiovascular disease

​

Dr. Lindsey’s funded research program uses a combination of in vivo, ex vivo, and in vitro approaches to assess sex differences in hypertension and vascular remodeling and the receptor signaling mechanisms utilized by sex hormones. We specifically focus on membrane-initiated estrogen signaling mediated by the G protein-coupled estrogen receptor. Our overall goal is to elucidate sex hormone pharmacology to improve quality of life and reduce cardiovascular disease in aging women.

Biography >>